Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

Caroline Madsen; Kira Philipsen Prahm; Cecilia Nilsson; Lars Henning Pedersen; Morten Hanefeld Dziegiel; Morten Hedegaard

Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

Caroline Madsen, Kira Philipsen Prahm, Cecilia Nilsson, Lars Henning Pedersen, Morten Hanefeld Dziegiel, Morten Hedegaard

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopenia
Foetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.

Bidragets oversatte titel	Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopenia
Originalsprog	Dansk
Artikelnummer	V03170211
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	17
Sider (fra-til)	2-6
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 2018

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/opsaetning-af-screeningsprogram-i-danmark-foetal-og-neonatal-alloimmun-trombocytopeni

Citationsformater

@article{86f72c14ef2c4a86ad1ddb46bfb29df6,

title = "Ops{\ae}tning af screeningsprogram i Danmark for f{\o}tal og neonatal alloimmun trombocytopeni",

abstract = "Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.",

author = "Caroline Madsen and Prahm, {Kira Philipsen} and Cecilia Nilsson and Pedersen, {Lars Henning} and Dziegiel, {Morten Hanefeld} and Morten Hedegaard",

year = "2018",

language = "Dansk",

volume = "180",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "17",

}

TY - JOUR

T1 - Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

AU - Madsen, Caroline

AU - Prahm, Kira Philipsen

AU - Nilsson, Cecilia

AU - Pedersen, Lars Henning

AU - Dziegiel, Morten Hanefeld

AU - Hedegaard, Morten

PY - 2018

Y1 - 2018

N2 - Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.

AB - Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.

M3 - Tidsskriftartikel

C2 - 29717700

SN - 0041-5782

VL - 180

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 17

M1 - V03170211

ER -

Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater